Showing results (621-630 of 5,929) with videos related to

Sort By:
Pageof 593
The Prostate|January 11, 1992
Prostate specific antigen and prostatitis. II. PSA production and release kinetics in vitroT D Moon, S Clejan, D E Neal
The Prostate|January 1, 1992
NK cell activity in treated prostate cancer patients as a probe for circulating tumor cells: hormone regulatory effects in vivoM Kastelan, I Kraljić, M Tarle
The Prostate|January 1, 1992
Regulation of prostatic carcinoma cell proliferation and secretory activity by extracellular matrix and stromal secretionsC J Fong, E R Sherwood, E J Braun, et al.
The Prostate|January 1, 1992
Alpha 1-adrenoceptor properties of terazosin HCl and its enantiomers in the human prostate and canine brainS Meretyk, R Tang, E Shapiro, et al.
The Prostate|September 2, 2003
Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean peopleCristian Acevedo, Jose Luis Opazo, Christian Huidobro, et al.
The Prostate|September 2, 2003
Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinomaJun Luo, Thomas A Dunn, Charles M Ewing, et al.
The Prostate|September 2, 2003
Presence of neuroendocrine cells during postnatal development in rat prostate: Immunohistochemical, molecular, and quantitative studyRosario Rodríguez, José M Pozuelo, Rocío Martín, et al.
The Prostate|January 1, 1992
Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160S R Milovanovic, S Radulovic, K Groot, et al.
The Prostate|January 1, 1992
Prognostic significance of antigenic heterogeneity, Gleason grade, and ploidy of lymph node metastases in patients with prostate cancerM Bazinet, S M Hamdy, L R Bégin, et al.
The Prostate|January 13, 2004
Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell lineC B Lazier, L N Thomas, R C Douglas, et al.
Pageof 593